Table 2.
The EIF1AX expression in endometrial carcinoma, precursor lesions, and normal endometrium.
| Groups | n | Cytoplasmic EIF1AX expression | Nuclear EIF1AX expression | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | + | ++ | +++ | ++++ | PR (%) | — | + | ++ | +++ | ++++ | PR (%) | ||
| NE | 50 | 48 | 0 | 0 | 2 | 0 | 4.0 | 2 | 0 | 0 | 2 | 46 | 96.0 |
| SEH | 50 | 49 | 0 | 0 | 1 | 0 | 2.0 | 1 | 0 | 0 | 4 | 45 | 98.0 |
| CEH | 50 | 40 | 0 | 1 | 9 | 0 | 20.0 | 5 | 0 | 0 | 3 | 42 | 90.0 |
| AEH | 50 | 18 | 5 | 7 | 20 | 0 | 64.0 | 8 | 2 | 38 | 2 | 0 | 84.0 |
| EEC | 286 | 50 | 50 | 100 | 59 | 27 | 82.5a,b,c,d | 249 | 21 | 10 | 3 | 3 | 12.9a,b,c,d |
| EC | 315 | 56 | 52 | 104 | 65 | 38 | 82.2a | 272 | 22 | 12 | 5 | 4 | 13.7a |
a P < 0.01, compared with normal endometrium; bP < 0.01, compared with SEH; cP < 0.01, compared with CEH; dP < 0.01, compared with AEH; NE: normal endometrium; SEH: simple endometrial hyperplasia; CEH: complex endometrial hyperplasia; AEH: endometrial atypical hyperplasia; PR: positive rate.